- Novo Nordisk has been trading places with LVMH for the title of Europe's most valuable company.
- The Danish pharmaceutical giant makes the buzzy weight-loss drugs Wegovy and Ozempic.
- Its at-home injections are in high demand, but some insurers say they won't cover the high prices.
Novo Nordisk, the maker of weight-loss drug Wegovy and diabetes drug Ozempic, has been trading places with French luxury-goods conglomerate LVMH for the title of now Europe's most valuable firm.